Name: Autoimmune Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: PH4058
Price: 4350 USD
Availability: InStock

Autoimmune Treatment Market Size Share Growth Opportunities and Forecast 2024

Autoimmune Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>Market Snippet by &nbsp;Drug Class</li>
		<li>Market snippet by Indication</li>
		<li>Market Snippet by Distribution Channel</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rise in the Prevalence of Autoimmune Diseases</li>
				<li>Increasing Investments in Research and development</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Higher Cost of Therapeutics</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>
	<h3>COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3>By Drug Class</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class Segment</li>
			<li>Market Attractiveness Index, By Drug Class Segment</li>
		</ol>
		</li>
		<li>Anti-Inflammatory *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Anti-Hyperglycemic</li>
		<li>NSAIDs</li>
		<li>Interferons</li>
		<li>Other</li>
	</ol>
	</li>
	<li>
	<h3>By Indication</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Attractiveness Index, By Indication</li>
		</ol>
		</li>
		<li>Rheumatic Disease *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Diabetes</li>
		<li>Multiple Sclerosis</li>
		<li>Inflammatory Bowel Disease</li>
		<li>Other</li>
	</ol>
	</li>
	<li>
	<h3>By Distribution Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment</li>
			<li>Market Attractiveness Index, By Distribution Channel Segment</li>
		</ol>
		</li>
		<li>Hospital Pharmacy *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Pharmacy Stores</li>
		<li>Other</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>&nbsp;</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
		<li>List of key companies to watch</li>
		<li>List of the company with disruptive technology</li>
		<li>List of start-up companies</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>Abbott Laboratories*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Amgen</li>
		<li>Johnson &amp; Johnson</li>
		<li>Eli Lilly &amp; Co.</li>
		<li>&nbsp;Pfizer</li>
		<li>&nbsp;Roche</li>
		<li>&nbsp;Astrazeneca Plc</li>
		<li>&nbsp;Bristol-Myers Squibb Co.</li>
		<li>GlaxoSmithKline Plc</li>
		<li>Lupin Limited.(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>
	<h3>DataM Intelligence</h3>

	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h3>List of Tables</h3>

Table 01 Global Autoimmune Treatment Market Value, By Drug Class, 2021, 2025 &amp; 2029 ($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 02 Global Autoimmune Treatment Market Value, By Indication, 2021, 2025 &amp; 2029 ($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 03 Global Autoimmune Treatment Market Value, By Distribution Channel, 2021, 2025 &amp; 2029 ($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 04 Global Autoimmune Treatment Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 05 Global Autoimmune Treatment Market Value, By Drug Class, 2021, 2025 &amp; 2029 ($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 06 Global Autoimmune Treatment Market Value, By Drug Class, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 07 Global Autoimmune Treatment Market Value, By Indication, 2021, 2025 &amp; 2029 ($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 08 Global Autoimmune Treatment Market Value, By Indication, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 09 Global Autoimmune Treatment Market Value, By Distribution Channel, 2021, 2025 &amp; 2029 ($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 10 Global Autoimmune Treatment Market Value, By Distribution Channel, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 11 Global Autoimmune Treatment Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 12 Global Autoimmune Treatment Market Value, By Region, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 13 North America Autoimmune Treatment Market Value, By Drug Class, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 14 North America Autoimmune Treatment Market Value, By Indication, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 15 North America Autoimmune Treatment Market Value, By Distribution Channel, 2019-2029($ Million) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 17 North America Autoimmune Treatment Market Value, By Country, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 18 South America Autoimmune Treatment Market Value, By Drug Class, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 19 South America Autoimmune Treatment Market Value, By Indication, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 20 South America Autoimmune Treatment Market Value, By Distribution Channel, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 21 South America Autoimmune Treatment Market Value, By Country, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 22 Europe Autoimmune Treatment Market Value, By Drug Class, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 23 Europe Autoimmune Treatment Market Value, By Indication, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 24 Europe Autoimmune Treatment Market Value, By Distribution Channel, 2019-2029($ Million) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 25 Europe Autoimmune Treatment Market Value, By Country, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 26 Asia-Pacific Autoimmune Treatment Market Value, By Drug Class, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 27 Asia-Pacific Autoimmune Treatment Market Value, By Indication, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 28 Asia-Pacific Autoimmune Treatment Market Value, By Distribution Channel, 2019-2029($ Million)

Table 29 Asia-Pacific Autoimmune Treatment Market Value, By Country, 2019-2029($ Million)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 30 Middle East &amp; Africa Autoimmune Treatment Market Value, By Drug Class, 2019-2029($ Million)

Table 31 Middle East &amp; Africa Autoimmune Treatment Market Value, By Indication, 2019-2029($ Million)

Table 32 Middle East &amp; Africa Autoimmune Treatment Market Value, By Distribution Channel, 2019-2029($ Million) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 33 Abbott Laboratories: Overview&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 34 Abbott Laboratories: Product Portfolio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 35 Abbott Laboratories: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 36 Amgen: Overview&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 37 Amgen: Product Portfolio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 38 Amgen: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 39 Johnson &amp; Johnson: Overview&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 40 Johnson &amp; Johnson: Product Portfolio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 41 Johnson &amp; Johnson: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 42 Eli Lilly &amp; Co: Overview&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 43 Eli Lilly &amp; Co: Product Portfolio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 44 Eli Lilly &amp; Co: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 45 Pfizer: Overview&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 46 Pfizer: Product Portfolio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 47 Pfizer: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 48 Roche: Overview&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 49 Roche: Product Portfolio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 50 Roche: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 51 Astrazeneca Plc: Overview&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 52 Astrazeneca Plc: Product Portfolio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 53 Astrazeneca Plc: Key Developments&nbsp;&nbsp;&nbsp;

Table 54 Bristol-Myers Squibb Co.: Overview&nbsp;&nbsp;&nbsp;

Table 55 Bristol-Myers Squibb Co.: Product Portfolio&nbsp;&nbsp;&nbsp;

Table 56 Bristol-Myers Squibb Co.: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 57 GlaxoSmithKline Plc: Overview&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 58 GlaxoSmithKline Plc: Product Portfolio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 59 GlaxoSmithKline Plc: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 60 Lupin Limited: Overview&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 61 Lupin Limited: Product Portfolio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Table 62 Lupin Limited: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<h3>&nbsp;List of Figures</h3>

Figure 01 Global Autoimmune Treatment Market Share, By Drug Class, 2019 &amp; 2027 (%)

Figure 02 Global Autoimmune Treatment Market Share, By Indication, 2019 &amp; 2027 (%)

Figure 03 Global Autoimmune Treatment Market Share, By Distribution Channel, 2019 &amp; 2027 (%)

Figure 04 Global Autoimmune Treatment Market Share, By Region, 2019 &amp; 2027 (%)

Figure 05 Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 06 Global Autoimmune Treatment Market Y-o-Y Growth, By Drug Class, 2019-2027 (%)

Figure 07 Anti-Inflammatory: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 08 Anti-Hyperglycemic: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 09 NSAIDs: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 10 Interferons: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 11 Other: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 12 Global Autoimmune Treatment Market Y-o-Y Growth, By Indication, 2019-2027 (%)

Figure 13 Rheumatic Disease: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 14 Diabetes: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 15 Multiple Sclerosis: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 16 Inflammatory Bowel Disease: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 17 Other: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 18 Global Autoimmune Treatment Market Y-o-Y Growth, By Distribution Channel, 2019-2027 (%)

Figure 19 Hospital Pharmacy: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 20 Pharmacy Stores: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 21 Other: Global Autoimmune Treatment Market Value, 2019-2029($ Million)

-2027 ($ Million)

Figure 22 Global Autoimmune Treatment Market Y-o-Y Growth, By Region, 2019-2027 (%)

Figure 23 North America Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 24 North America Autoimmune Treatment Market Share, By Drug Class, 2019 &amp; 2027 (%)

Figure 25 North America Autoimmune Treatment Market Share, By Indication, 2019 &amp; 2027 (%)

Figure 26 North America Autoimmune Treatment Market Share, By Distribution Channel, 2019 &amp; 2027 (%)

Figure 27 North America Autoimmune Treatment Market Share, By Country, 2019 &amp; 2027 (%)

Figure 27 South America Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 28 South America Autoimmune Treatment Market Share, By Drug Class, 2019 &amp; 2027 (%)

Figure 29 South America Autoimmune Treatment Market Share, By Indication, 2019 &amp; 2027 (%)

Figure 30 South America Autoimmune Treatment Market Share, By Distribution Channel, 2019 &amp; 2027 (%)

Figure 31 South America Autoimmune Treatment Market Share, By Country, 2019 &amp; 2027 (%)

Figure 32 Europe Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 33 Europe Autoimmune Treatment Market Share, By Drug Class, 2019 &amp; 2027 (%)

Figure 34 Europe Autoimmune Treatment Market Share, By Indication, 2019 &amp; 2027 (%)

Figure 35 Europe Autoimmune Treatment Market Share, By Distribution Channel, 2019 &amp; 2027 (%)

Figure 36 Europe Autoimmune Treatment Market Share, By Country, 2019 &amp; 2027 (%)

Figure 37 Asia-Pacific Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 38 Asia-Pacific Autoimmune Treatment Market Share, By Drug Class, 2019 &amp; 2027 (%)

Figure 39 Asia-Pacific Autoimmune Treatment Market Share, By Indication, 2019 &amp; 2027 (%)

Figure 40 Asia-Pacific Autoimmune Treatment Market Share, By Distribution Channel, 2019 &amp; 2027 (%)

Figure 41 Asia-Pacific Autoimmune Treatment Market Share, By Country, 2019 &amp; 2027 (%)

Figure 42 Middle East &amp; Africa Autoimmune Treatment Market Value, 2019-2029($ Million)

Figure 43 Middle East &amp; Africa Autoimmune Treatment Market Share, By Drug Class, 2019 &amp; 2027 (%)

Figure 44 Middle East &amp; Africa Autoimmune Treatment Market Share, By Indication, 2019 &amp; 2027 (%)

Figure 45 Middle East &amp; Africa Autoimmune Treatment Market Share, By Distribution Channel, 2019 &amp; 2027 (%)

Figure 46 Abbott Laboratories: Financials

Figure 47 Amgen: Financials

Figure 48 Johnson &amp; Johnson: Financials

Figure 49 Eli Lilly &amp; Co: Financials

Figure 50 Pfizer: Financials

Figure 51 Roche: Financials

Figure 52 Astrazeneca Plc: Financials

Figure 53 Bristol-Myers Squibb Co.: Financials

Figure 54 GlaxoSmithKline Plc: Financials

Figure 55 Lupin Limited: Financials

Autoimmune Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Anti-malarial Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 01

Starting from

Atypical Chemokine Receptor 3 Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 01

Starting from

Interferons Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 01

Starting from

Trypsin Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 01

Starting from

Fetal Bovine Serum Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 29

Starting from

Gynecological Cancers Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 01

Starting from